FDA Announces New PreCheck Program to Bolster Regulatory Predictability

The program is also meant to facilitate construction of drug manufacturing sites in the U.S.

The FDA has announced a new program called FDA PreCheck, meant to increase “regulatory predictability and [facilitate] the construction of manufacturing sites in the U.S.”

The program is meant to bolster America’s domestic drug supply. As of now, “more than half of pharmaceuticals distributed in the U.S. are manufactured overseas,” and the U.S. is reliant on overseas sources for “active pharmaceutical ingredients (APIs).”

FDA PreCheck was developed in response to an executive order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines.” The order “directs FDA to streamline review of domestic pharmaceutical manufacturing and eliminate unnecessary regulatory requirements while maximizing review timeliness and predictability.”

The PreCheck program introduces a two-phase approach. The first phase is called the “Facility Readiness Phase,” which “provides manufacturers with more frequent FDA communication at critical development stages, including facility design, construction, and pre-production. This phase also encourages companies to provide comprehensive facility-specific information through a Type V Drug Master File (DMF).” The next phase is the “Application Submission Phase,” which “centers on streamlining development of the Chemistry, Manufacturing, and Controls section of the application through pre-application meetings and early feedback.”

About the Author

Matt MacKenzie

Matt MacKenzie

Associate Editor

Matt MacKenzie is Senior Staff Writer and Associate Editor of Healthcare Purchasing News (HPN), where he leads daily news coverage and contributes in-depth features on healthcare supply chain, sterile processing, infection prevention and clinical operations. Through industry reporting and expert interviews, he examines the trends, technologies and operational challenges shaping healthcare purchasing and patient care. 

Sign up for our eNewsletters
Get the latest news and updates